• Home
  • Information
  • Site Map
  • Print
  • Contact Us
  • Members Area
Basque Government SPRI
Decorative Image

News

  • Faes Farma licenses Pierre Fabre to market Bilastine in France and Belgium

  • The Basque pharmaceutical company Faes Farma and Menarini, the latter having the rights to market Bilastine in 51 countries, came to an agreement with the French multinational company Pierre Fabre to market a second Bilastine brand in France and Belgium. Menarini and Pierre Fabre's joint effort will enable patients to make use of this molecule researched and developed by the Basque firm for the treatment of rhinitis and urticaria.

  • Read more >>

  • July 16, 2010

More news of 2010